500 attendees
OPT Congress
Mar 18–19, 2026Boston, US
500
Attendees
92
Speakers
16
Sponsors
33
Exhibitors
About
OPT Congress highlights next-generation oligonucleotide therapies in drug development, discovery, delivery, CMC, Regulatory and mRNA therapeutics
Speakers (92)
View all 92 →AS
Adebowale Shoroye
Biogen
AG
Adi Gilboa-Geffen
Eleven Therapeutics
AR
Adrian R Krainer
Cold Spring Harbor Lab
AL
Aimee L Jackson
Jackson Biosciences
AM
Ajit Magadum
University of South Florida
AG
Akash Gupta
Massachusetts Institute of Technology
AH
Alan Horsager
Concept Bio
AN
Alan Nafiiev
Receptor.AI
AZ
Alex Zinoviev
Eli Lilly & Co.
AL
Amit Luthra
Dyne Therapeutics Inc.
AN
Amit Nayyar
Cohance
AK
Anastasia Khvorova
University of Massachusetts Medical School
Sponsors (16)
20+3 Millions50+85,000+Cookie PolicyEVENT MARKETINGExhibit Savings DeadlineFinal Brochure DeadlineFOR MORE INFORMATION REGARDING EXHIBIT AND SPONSORSHIP, PLEASE CONTACT:KEY DEADLINESlinkedin#OPTBostonPAST ATTENDEE DEMOGRAPHICSPreliminary Web-Based AgendaProgram Guide Deadline[Twitter](https://twitter.com/CHI_Healthtech)
Exhibitors (33)
150+ Unique Organizations300+ Attendees4 Conferences60+ SpeakersAccess Digital PlatformBrenda Bass, PhDCalendarCHI | Cambridge HealthTech InstituteConference Image Gallery CarouselDebra MillerDownload 2026 brochureEvent Highlights and Testimonials VideoExhibit Savings DeadlineExhibit Savings Deadline| TBAFacebookFinal Brochure DeadlineKEY DEADLINESlinkedinMano Manoharan, PhDOPT Congress 2026OPT Congress - Oligonucleotide & mRNA TherapeuticsPreliminary Web-Based AgendaPreliminary Web-Based Agenda| TBAPresent a PosterProgram Guide DeadlineRegister Early For Maximum SavingsShort Course 1: Safety & Toxicity of Nucleic AcidsShort CoursesSponsor and ExhibitTimothy Yu, PhD+3 more